Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AMO chases contacts after Visx merger

This article was originally published in The Gray Sheet

Executive Summary

Advanced Medical Optics will seek acquisitions in contact lens arena - potentially competing with giants Ciba Vision, Bausch & Lomb and J&J/Vistakon. AMO inked a July pact to market CooperVision's hydrogel contact lenses in Europe and the Asia-Pacific under its Complete eye care line, with the lenses branded as Aquavision. The licensing deal allows AMO to test the waters "before we jump in," Mazzo says at First Albany Capital analyst conference Dec. 7. The firm expects its $1.27 bil. acquisition of Visx to close in Q1 2005...

You may also be interested in...

AMO Deciding Whether To Enter Contact Lens, Dry Eye Markets

Advanced Medical Optics will decide this year if it will make a long-term commitment in the contact lens sector

ICER Partnering With Aetion To Scale Up Use Of RWE In Value Assessments

Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.

‘Highly Questionable’ GMP Compliance In Pakistan Prompts New Licensing System

Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts